NoIR 15% Medium Amber SpectraShield, Small
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are specialty filtered sunglasses that block 100% of UV light while allowing only 15% of visible light through an amber-tinted lens — a combination designed to reduce glare significantly without plunging the wearer into darkness. They're particularly suited for people with conditions like macular degeneration, glaucoma, cataracts, or diabetic retinopathy, where the eye is more sensitive to bright light and glare can seriously impair functional vision. The frame includes a top ridge to block overhead light and side shields integrated into the frame, making them more protective than standard sunglasses — and they fit over prescription glasses, so you don't need a custom pair. The 15% transmission level is fairly dark, which works well outdoors or in bright artificial lighting but may feel too dim for low-light indoor environments.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Medicaid waiver
- Out of pocket
What Setup Looks Like
- Out of the box
- Put them on — wear alone or slip over existing prescription glasses.
- No adjustments or programming required; useful immediately in bright or outdoor conditions.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.